Seattle Genetics | 営業利益

Operating Profit 変化する 日付
AbbVie USD 3.2B 914M 2023-12
Acadia Pharmaceuticals USD 34.94M 92.72M 2023-12
Agios Pharmaceuticals USD -106277000 5.38M 2023-12
Amgen USD 1.27B 819M 2023-12
Bayer EUR -3594000000 2.64B 2023-09
Bristol-Myers Squibb USD 1.85B 473M 2023-12
Celldex Therapeutics USD -47627000 6.39M 2023-12
Eisai JPY 5.4B 20.63B 2023-09
Eli Lilly USD 2.39B 1.94B 2023-12
Exelixis USD -17583000 95.43M 2023-09
Genmab DKK 1.72B 220M 2023-09
Gilead Sciences USD 1.61B 1.01B 2023-12
GlaxoSmithKline GBP 1.95B 192M 2023-09
Incyte USD 187.27M 27.44M 2023-12
Insmed USD -178272000 30.6M 2023-12
Moderna USD 6M 2.02B 2023-12
Pfizer USD -6551000000 3.61B 2023-12
Regeneron Pharmaceuticals USD 972.9M 138.1M 2023-12
Sarepta Therapeutics USD -48342000 16.82M 2023-09
Takeda JPY -49342000000 217.91B 2023-09
Teva Pharmaceutical Industries USD 355M 1B 2023-09
Vertex Pharmaceuticals USD 1.04B 11.7M 2023-09
Xencor USD -35009000 16.74M 2023-12



Seattle Genetics 営業利益 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Apr 2024.